Technology GenSight Biologics Raises Awareness of Leber Hereditary Optic Neuropathy (LHON) Business Wire Feb 28, 2023 GenSight Biologics, a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and…
Life Sciences GenSight Biologics Announces Publication of a Study of the Impact of LHON Disease on the Lives of… AIT News Desk May 24, 2022 Study is first of its kind to explore the impact of LHON on patients and their relatives in four different countries Study…